Virtu Financial LLC Denali Therapeutics Inc. Transaction History

Virtu Financial LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 26, 2024	BUY	$16.2 - $23.18 $252,331 - $361,051	15,576 New	15,576 $334,000
Q1 2021 May 19, 2021	SELL	$53.8 - $81.53 $181,467 - $275,000	-3,373 Closed	0 $0
Q4 2020 Feb 24, 2021	SELL	$36.89 - $93.56 $163,348 - $414,283	-4,428 Reduced 56.76%	3,373 $283,000
Q3 2020 Dec 11, 2020	BUY	$23.13 - $38.84 $180,437 - $302,990	7,801 New	7,801 $280,000
Q4 2019 Feb 04, 2020	SELL	$14.4 - $19.99 $152,841 - $212,173	-10,614 Closed	0 $0
Q3 2019 Nov 20, 2019	BUY	$15.32 - $21.92 $162,606 - $232,658	10,614 New	10,614 $163,000
Q2 2018 Jul 30, 2018	SELL	$15.25 - $21.02 $187,178 - $257,999	-12,274 Closed	0 $0
Q2 2018 Jul 30, 2018	BUY	$15.25 - $21.02 $187,178 - $257,999	12,274 New	12,274 $187,000

226

119M

60.6K

48.4K

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $3.13B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.